1 completed, 1 unknown, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
Follow Cytokine Storm: new trials by email Literature Review of Cytokine Storm trials Research Report on Cytokine Storm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis Dexamethasone, Etoposide, Ruxolitinib - Hemophagocytic Lymphohistiocytoses, Cytokine Storm | Phase 4 | Unknown | The Children's Hospital of Zhejiang University School of Medicine | 400 | 2022-09-01 | 2022-10-06 |
| High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19 Methylprednisolone, Tocilizumab - COVID-19 Virus Infection, Cytokine Storm | Phase 4 | Withdrawn | Marmara University | 2021-02-01 | 2021-11-24 | |
| Fluoxetine to Reduce Intubation and Death After COVID19 Infection Fluoxetine - COVID-19, Cytokine Storm | Phase 4 | Completed | University of Toledo Health Science Campus | 16 | 2020-05-01 | 2024-06-07 |
Cytokine Release Syndrome (3) · COVID-19 (2) · Lymphohistiocytosis, Hemophagocytic (1)
Inflammation (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Shock (3) · Systemic Inflammatory Response Syndrome (3) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2)
Adrenal Cortex Hormones (2) · Dexamethasone (1) · Etoposide (1) · Fluoxetine (1) · Methylprednisolone (1) · Steroids (1) · ruxolitinib (1) · tocilizumab (1)
Marmara University (1) · The Children's Hospital of Zhejiang University School of Medicine (1) · University of Toledo Health Science Campus (1)
China (1) · United States (1)
Ruslan Abdullayev (1) · Xiaojun Xu, MD (1) · Yongmin Tang, MD (1)